BR0111799A - Medicamentos para a prevenção e o tratamento de doenças neurodegenerativas - Google Patents

Medicamentos para a prevenção e o tratamento de doenças neurodegenerativas

Info

Publication number
BR0111799A
BR0111799A BR0111799-8A BR0111799A BR0111799A BR 0111799 A BR0111799 A BR 0111799A BR 0111799 A BR0111799 A BR 0111799A BR 0111799 A BR0111799 A BR 0111799A
Authority
BR
Brazil
Prior art keywords
prevention
treatment
neurodegenerative diseases
substituted
medicines
Prior art date
Application number
BR0111799-8A
Other languages
English (en)
Inventor
Kiyoshi Furukawa
Satoshi Kurumiya
Kazuo Okimoto
Kazunori Ohno
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of BR0111799A publication Critical patent/BR0111799A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"MEDICAMENTOS PARA A PREVENçãO E O TRATAMENTO DE DOENçAS NEURODEGENERATIVAS". Medicamentos para a prevenção e o tratamento de doenças neurodegenerativas, que são utilizáveis na prevenção e/ou tratamento de doenças neurodegenerativas como doença de Alzheimer e esquizofrenia em mamíferos (incluindo seres humanos), mediante retardamento ou inibição da neurodegeneração devida à hipofunção do receptor de ácido glutâmico, e que contêm como ingrediente ativo derivados de 3-oxadiazolil-1,6-naftiridin-2(1H)-ona 5-substituídos de fórmula genérica (I) ou seus sais de adição de ácido fisiologicamente aceitáveis, em que Het é oxadiazolil; R^ 1^ é hidrogênio, alquila inferior, cicloalquila inferior, alcenila inferior, alcóxi inferior, arila substituída ou não substituída, heteroarila substituída ou não substituída, ou outros; e R^ 2^ é hidrogênio, alquila inferior, cicloalquila inferior, arila substituída ou não substituída, ou outros.
BR0111799-8A 2000-06-21 2001-06-12 Medicamentos para a prevenção e o tratamento de doenças neurodegenerativas BR0111799A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000185814 2000-06-21
PCT/JP2001/004934 WO2001098300A1 (fr) 2000-06-21 2001-06-12 Medicaments utilises dans la prevention et le traitement de maladies neurodegeneratives

Publications (1)

Publication Number Publication Date
BR0111799A true BR0111799A (pt) 2003-05-27

Family

ID=18686074

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111799-8A BR0111799A (pt) 2000-06-21 2001-06-12 Medicamentos para a prevenção e o tratamento de doenças neurodegenerativas

Country Status (19)

Country Link
US (1) US6743803B2 (pt)
EP (1) EP1295883A4 (pt)
KR (1) KR20030010740A (pt)
CN (1) CN100354274C (pt)
AU (2) AU2001262741B2 (pt)
BR (1) BR0111799A (pt)
CA (1) CA2412199A1 (pt)
CZ (1) CZ20024153A3 (pt)
EE (1) EE04941B1 (pt)
HU (1) HUP0301319A3 (pt)
IL (2) IL153439A0 (pt)
MX (1) MXPA02012599A (pt)
NO (1) NO20026148L (pt)
NZ (1) NZ523189A (pt)
PL (1) PL200537B1 (pt)
RU (1) RU2258506C2 (pt)
SK (1) SK17682002A3 (pt)
TW (1) TWI298068B (pt)
WO (1) WO2001098300A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6822097B1 (en) * 2002-02-07 2004-11-23 Amgen, Inc. Compounds and methods of uses
TW200533371A (en) * 2004-04-15 2005-10-16 Dainippon Pharmaceutical Co Medicament comprising a combination of an acetylcholinesterase inhibitor and a 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivative
EP1595881A1 (en) 2004-05-12 2005-11-16 Pfizer Limited Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands
WO2010002451A1 (en) * 2008-07-01 2010-01-07 Concert Pharmaceuticals, Inc. Naphthyridin derivatives
JP6551671B2 (ja) * 2015-08-11 2019-07-31 国立大学法人 熊本大学 アルツハイマー治療薬
MX2022000693A (es) * 2019-07-18 2022-05-26 Abaxys Therapeutics Formulacion solida de un derivado de 1,2,4-oxadiazol.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2683818B1 (fr) 1991-11-14 1993-12-31 Adir Cie Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JPH09291034A (ja) 1996-02-27 1997-11-11 Yoshitomi Pharmaceut Ind Ltd 縮合ピリジン化合物およびその医薬としての用途
ZA985870B (en) * 1997-07-15 1999-01-27 Dainippon Pharmaceutical Co 5-substituted-3-oxadiazolyl-1, 6-naphthyridin-2(1H)-one derivatives
AR013184A1 (es) * 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
CH1196397H1 (de) 1999-06-02 2007-05-31 Nps Pharma Inc Metabotrope Glutamatrezeptorantagonisten zur Behandlung von Krankheiten des zentralen Nervensystems.

Also Published As

Publication number Publication date
PL363869A1 (en) 2004-11-29
CZ20024153A3 (cs) 2003-06-18
TWI298068B (en) 2008-06-21
IL153439A (en) 2007-07-24
NO20026148D0 (no) 2002-12-20
AU2001262741B2 (en) 2005-07-07
US6743803B2 (en) 2004-06-01
EE200200698A (et) 2004-08-16
RU2258506C2 (ru) 2005-08-20
HUP0301319A2 (hu) 2003-09-29
SK17682002A3 (sk) 2003-08-05
AU6274101A (en) 2002-01-02
PL200537B1 (pl) 2009-01-30
EE04941B1 (et) 2007-12-17
CA2412199A1 (en) 2001-12-27
WO2001098300A1 (fr) 2001-12-27
EP1295883A4 (en) 2003-06-11
NO20026148L (no) 2003-02-20
HUP0301319A3 (en) 2008-06-30
EP1295883A1 (en) 2003-03-26
NZ523189A (en) 2004-08-27
MXPA02012599A (es) 2003-05-14
US20030166673A1 (en) 2003-09-04
CN1447809A (zh) 2003-10-08
KR20030010740A (ko) 2003-02-05
CN100354274C (zh) 2007-12-12
IL153439A0 (en) 2003-07-06

Similar Documents

Publication Publication Date Title
BRPI0415863A (pt) derivados pirazina e seus usos farmacêuticos
BRPI0616574A2 (pt) derivado de sulfonamida tendo atividade antagonìstica de receptor de pgd2
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
BRPI0606817A2 (pt) derivados de piridazina e seu uso como agentes terapêuticos
BR0314393A (pt) Piperazinas heterocìclicas substituìdas para o tratamento de esquizofrenia
EA200801184A1 (ru) Производные пипередин-4-ил-пиридазин-3-иламина как быстро диссоциирующие антагонисты рецептора дофамина 2
DE60010076D1 (de) Chinolinderivate als antibakterielle mittel
BRPI0511874A (pt) derivados da pirrolopiridina
BR0317600A (pt) ácidos heteroarilalcanóicos como derivados de antagonistas de receptor de integrina
BRPI0417208A (pt) derivados de 8'-piri(mi)dinil-diidroespiro-[cicloalquilamina]-pirimid o[1,2-ona]pirimidin-6-ona
BR112012008518A2 (pt) derivado heterocíclico, e, composição farmacêutica
NO20085087L (no) Nye heterocykliske forbindelser
BRPI0416989A (pt) derivados aminopirazole como inibidores gsk-3
BR0210028A (pt) Agentes antibacterianos
BRPI0408605A (pt) derivados de 8-perfluoralquil-6,7,8,9-tetrahidropirimido[1,2-a]piri midin-4-ona substituìdos
UY27592A1 (es) Nuevo uso
BRPI0408189A (pt) 8'-piridinil-dihidroespiro-[cicloalquil]-pirimido[1,2-a]p irimidin-6-ona substituìda e derivados de 8'-pirimidinil-dihidroespiro-[cicloalquil]-pirimido[1,2- a]pirimidin-6-ona e seus usos contra doenças neurodegenerativas
WO2007046867A3 (en) Piperidine derivatives and their uses as therapeutic agents
AR043658A1 (es) Derivados 8-substituidos-6,7,8,9-tetrahidropirimido[1,2-a]pirimidin-4-ona
BR0308109A (pt) Derivados 2-piridinil e 2-pirimidinil-6,7,8,9-tetraidro-pirimido[1,2-a] pirimidin-4-ona substituìdos com hetero arila
NO20073250L (no) Non-anilinderivater av isotiazol-3- (2H)-on 1,1-dioksider som lever-X-reseptor modulerende forbindelser.
NO324219B1 (no) Fenylpyridazin-forbindelser, medisiner og farmasoytiske preparater inneholdende disse samt anvendelse av disse for fremstilling av medikamenter for behandling av sykdom
BRPI0507757A (pt) composto, composição farmacêutica, e agente terapêutico para uma doença na qual a angiogênese ou a hipermeabilidade vascular está envolvida
BR0111799A (pt) Medicamentos para a prevenção e o tratamento de doenças neurodegenerativas
BR0314796A (pt) Piperazinas substituìdas heterocìclicas para o tratamento de esquizofrenia

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.